This is the limited version of the Dako company profile: Join LinkedIn or Sign In to see more information.
Dako, based in Denmark, is a global leader in tissue-based cancer diagnostics. Hospital and research laboratories worldwide use Dako’s knowledge, reagents, instruments and software to make precise diagnoses and determine the most effective treatment for patients suffering from cancer. Employing more than 1000 people and operating in more than 70 countries, Dako covers essentially all of the global anatomic pathology markets. Dako is owned by a private equity fund, EQT.
New Hires and Recent Promotions at Dako
-
was Global Product Manager - 2 months ago
-
Jesper Hejselbæk, Director, Financial Controlling & Reporting
was Consolidation Manager - 6 months ago
-
Kasper Markussen, Director, Sales & Marketing Business Controlling
was Sales Analyst Manager - 6 months ago
-
was Executive Assistant - 4 months ago
Last edited by Global Events Manager at Dako
Produktionsvej 42
Glostrup
2600
Denmark
Phone: 45 44 85 95 00
Fax: 45 44 85 95 95
| Headquarters | Copenhagen Area, Denmark |
|---|
| Industry | Biotechnology |
|---|
| Type | Privately Held |
|---|
| Status | Operating |
|---|
| Company Size |
1,000 employees
|
|---|
| Founded | 1966 |
|---|
| Website | http://www.dako.com |
|---|
| Top Schools |
| Københavns Universitet | 9% |
| Danmarks Tekniske Universitet | 7% |
| Copenhagen Bus. School | 7% |
| Handelshøjskolen i København | 6% |
| Univ. of California, Santa Barbara | 5% |
|
Estimated based on LinkedIn Data
Career path for Dako employees
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about Dako. This page is not endorsed by or affiliated with Dako. For questions regarding LinkedIn Company Profiles, contact us.
